Tenax Therapeutics (TENX) Non Operating Investment Income (2014 - 2021)
Tenax Therapeutics recorded quarterly Non Operating Investment Income of $2.0 in Q4 2021, up 100.72% quarter-over-quarter from -$276.0 in Q3 2021, and down 99.79% year-over-year from $973.0 in Q4 2020.
Tenax Therapeutics' Non Operating Investment Income history runs 8 years deep, the most recent figure standing at $2.0 for Q4 2021.
- In Q4 2021, Non Operating Investment Income fell 99.79% year-over-year to $2.0; the TTM figure through Sep 2022 stood at $2.0 (down 99.78% YoY), while the FY2021 annual figure was -$70.0, down 113.26% from the prior year.
- Non Operating Investment Income came in at $2.0 for Q4 2021 at Tenax Therapeutics, up from -$276.0 in the prior quarter.
- In the past five years, Non Operating Investment Income ranged from a high of $10857.0 in Q1 2018 to a low of -$10556.0 in Q2 2018.
- A 5-year average of -$936.05 and a median of -$202.0 in 2021 frame the typical range for Non Operating Investment Income.
- Across the five-year window, Non Operating Investment Income jumped 265.93% in 2018 and sank 583.12% in 2020, its largest moves.
- Tenax Therapeutics' Non Operating Investment Income stood at $10444.0 in 2017, then plunged by 200.51% to -$10497.0 in 2018, then soared by 108.2% to $861.0 in 2019, then rose by 13.01% to $973.0 in 2020, then plunged by 99.79% to $2.0 in 2021.
- According to Business Quant data, Non Operating Investment Income over the past three periods registered $2.0, -$276.0, and -$128.0 for Q4 2021, Q3 2021, and Q2 2021 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 235,807.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 230,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Tenax Therapeutics | 542.72 Mn | 542.72 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 2.00 |
| Dec 31, 2021 | 2.00 |
| Sep 30, 2021 | -276.00 |
| Sep 30, 2021 | -276.00 |
| Jun 30, 2021 | -128.00 |
| Jun 30, 2021 | -128.00 |
| Mar 31, 2021 | 332.00 |
| Mar 31, 2021 | 332.00 |
| Dec 31, 2020 | 973.00 |
| Dec 31, 2020 | 973.00 |
| Sep 30, 2020 | 1,171.00 |
| Sep 30, 2020 | 1,171.00 |
| Jun 30, 2020 | -3,238.00 |
| Jun 30, 2020 | -3,238.00 |
| Mar 31, 2020 | 1,622.00 |
| Mar 31, 2020 | 1,622.00 |
| Dec 31, 2019 | 861.00 |
| Dec 31, 2019 | 861.00 |
| Sep 30, 2019 | 960.00 |
| Sep 30, 2019 | 960.00 |
| Jun 30, 2019 | -474.00 |
| Jun 30, 2019 | -474.00 |
| Mar 31, 2019 | -1,289.00 |
| Mar 31, 2019 | -1,289.00 |
| Dec 31, 2018 | -10,497.00 |
| Dec 31, 2018 | -10,497.00 |
| Sep 30, 2018 | -6,515.00 |
| Sep 30, 2018 | -6,515.00 |
| Jun 30, 2018 | -10,556.00 |
| Jun 30, 2018 | -10,556.00 |
| Mar 31, 2018 | 10,857.00 |
| Mar 31, 2018 | 10,857.00 |
| Dec 31, 2017 | 10,444.00 |
| Dec 31, 2017 | 10,444.00 |
| Sep 30, 2017 | -3,767.00 |
| Sep 30, 2017 | -3,767.00 |
| Jun 30, 2017 | -2,660.00 |
| Jun 30, 2017 | -2,660.00 |
| Mar 31, 2017 | -6,543.00 |
| Mar 31, 2017 | -6,543.00 |
| Dec 31, 2016 | 68,261.00 |
| Dec 31, 2016 | 68,261.00 |
| Sep 30, 2016 | 39,324.00 |
| Sep 30, 2016 | 39,324.00 |
| Jun 30, 2016 | -78,073.00 |
| Jun 30, 2016 | -78,073.00 |
| Mar 31, 2016 | -140,237.00 |
| Mar 31, 2016 | -140,237.00 |
| Dec 31, 2015 | 156,160.00 |
| Dec 31, 2015 | 156,160.00 |
| Sep 30, 2015 | -12,651.00 |
| Sep 30, 2015 | -12,651.00 |
| Jun 30, 2015 | 67,978.00 |
| Jun 30, 2015 | 67,978.00 |
| Jan 31, 2015 | -95,738.00 |
| Jan 31, 2015 | -95,738.00 |
| Oct 31, 2014 | -23,254.00 |
| Oct 31, 2014 | -23,254.00 |
| Jul 31, 2014 | 65,560.00 |
| Jul 31, 2014 | 65,560.00 |